Aurobindo Pharma Ltd announced that its wholly-owned arm, Eugia Pharma Specialties Ltd, has received final approval from the US health regulator for its generic version of Vasopressin injection.

The injection is indicated to increase blood pressure in adults who suffer from sudden relaxation of blood vessels, according to PTI.

The approval granted by the US Food and Drug Administration (USFDA) is for the manufacturing and marketing of vasopressin injection at a strength of 20 units per milliliter of multiple-dose vials, Aurobindo Pharma said in a regulatory filing.

Click for more on USFDA

The approved product is bioequivalent and therapeutically equivalent to the reference listed drug Vasostrict injection, 20 units/ml of Par Sterile Products, LLC (Par), it added.

Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shocks, such as due to post-cardiotomy or sepsis, and who remain hypotensive despite fluids and catecholamines.

The product will be launched immediately, the company said.

The approved product has an estimated market size of around USD 606 million for the 12 months ending June 2022, the company said, citing IQVIA data.

Other drugs approval by USFDA

USFDA gives approval for Meclizine HCL Tablets

USFDA gives nod for Prochlorperazine Maleate Tablets

USFDA gives approval generic Labetalol HCL tablets

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

USFDA gives final approval for Empagliflozin tablets

USFDA gives final approval to market this anti-inflammatory skin cream

Drug alert: 53 out of 1337 samples declared as NSQ in July 2022

CDSCO Panel gives nod for clinical trial of Elagolix 150 mg for Endometriosis

This drug can fight more than 300 drug-resistant bacteria

20 Blood Banks fined ₹2.3cr for overcharging

Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs

3 strategies to combat Counterfeit drugs and Pharma supply chain threats

USFDA gives approval for Meclizine HCL Tablets

Johnson & Johnson to end global sales of talc-based baby powder

USFDA gives nod for Prochlorperazine Maleate Tablets

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/08/17/usfda-approves-generic-vasopressin-injection/